OPTOMED OY A      EO 0,05
OPTOMED OY A EO 0,05
Aktie · FI4000410881 · A2PWGR (XHEL)
Übersicht
Kein Kurs
Schlusskurs XHEL 30.01.2026: 3,94 EUR
30.01.2026 16:29
Aktuelle Kurse von OPTOMED OY A EO 0,05
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XHEL: NASDAQ HELSINKI LTD
NASDAQ HELSINKI LTD
OPTOMED.HE
EUR
30.01.2026 16:29
3,94 EUR
0,13 EUR
+3,41 %
XFRA: Frankfurt
Frankfurt
36U0.F
EUR
30.01.2026 07:20
3,77 EUR
-0,19 EUR
-4,68 %
XDQU: Quotrix
Quotrix
OOYRSC81.DUSD
EUR
30.01.2026 06:27
3,82 EUR
-0,14 EUR
-3,42 %
XDUS: Düsseldorf
Düsseldorf
OOYRSC81.DUSB
EUR
29.01.2026 07:12
3,95 EUR
0,32 EUR
+8,98 %
Free Float & Liquidität
Free Float 69,83 %
Shares Float 14,97 M
Ausstehende Aktien 21,43 M
Firmenprofil zu OPTOMED OY A EO 0,05 Aktie
Optomed Oyj, a medical technology company, manufactures and sells handheld fundus cameras and screening software in Finland, China, and internationally. The company operates through two segments, Devices and Software segments. The company develops, manufactures, and sells fundus camera products, which are used by ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals. It offers camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Polaris, and Optomed Halo brands, as well as OEM cameras, including Pictor Plus, Pictor Prestige, Visuscout 100, Fundus Module 300, and Signal brand names. The company also provides Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases, such as diabetic retinopathy; Avenue Archive, an application software for displaying, archiving, and transmitting healthcare information; Avenue Telemedicine, a telemedicine solution for remote image analysis; Avenue AI, an automated diabetic retinopathy screening service; and Avenue Sync, a software solution for integrating fundus camera to the hospital image archive and worklist server. In addition, it offers Avenue Cancer Screen, a screening process management software for breast, cervical, and colorectal cancer; Optomed RIS, a software solution for healthcare imaging units for enhancing the diagnostic process and treatment decisions; Sectra PACS, a modular system optimized for use by high production healthcare providers; Optomed Service Portal, a support function for healthcare units that order and produce imaging services; Facad, a tracing software for visible light imaging and cephalometric measurements; and Sectra PACS Pathology, a digital pathology solution, which allows scanned glass slides to be distributed and diagnosed. Further, the company provides professional IT consulting services for government institutions. It sells its products and solutions through OEMs, distributors, and direct sales. The company's customers include hospitals, eye clinics, and optician chains and stores. The company was incorporated in 2004 and is headquartered in Oulu, Finland.
KI-Analyse von OPTOMED OY A EO 0,05
Wähle eine Analyse aus und der finAgent liefert dir tiefgehende Einblicke dazu!
Neuste KI Analysen zu OPTOMED OY A EO 0,05
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.

Unternehmensdaten

Name OPTOMED OY A EO 0,05
Firma Optomed Oyj
Website https://www.optomed.com
Heimatbörse XHEL Frankfurt
WKN A2PWGR
ISIN FI4000410881
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Healthcare Information Services
CEO Juho Himberg
Marktkapitalisierung 84 Mio
Land Finnland
Währung EUR
Mitarbeiter 0,1 T
Adresse Yrttipellontie 1, 90230 Oulu
IPO Datum 2019-12-05

Ticker Symbole

Name Symbol
NASDAQ HELSINKI LTD OPTOMED.HE
Düsseldorf OOYRSC81.DUSB
Frankfurt 36U0.F
Quotrix OOYRSC81.DUSD
Weitere Aktien
Investoren, die OPTOMED OY A EO 0,05 halten, haben auch folgende Aktien im Depot:
Axis NIFTY 50 ETF
Axis NIFTY 50 ETF ETF
Hollywall Entertainment, Inc.
Hollywall Entertainment, Inc. Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026